Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT: NCT06929702 · RECRUITING
광고
NCT IDNCT06929702
상태RECRUITING
시작일2025-07-09
완료2027-10-01
SponsorUniversity Hospital, Ghent (OTHER)
First posted
Last updated
간략 요약
The overall objective of this study is to investigate the impact of early model-informed precision dosing (MIPD) on target attainment of three beta-lactam antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem) in critically ill children. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.